30818-28-1

Basic information

• Product Name: Benzonitrile, 4-chloro-2-hydroxy-
• Synonyms: Benzonitrile, 4-chloro-2-hydroxy-;4-Chloro-2-hydroxy benzonitrile;5-Chloro-2-cyanophenol, 4-Chlorosalicylonitrile;4-Chlorosalicylonitrile;5-Chloro-2-cyanophenol
• CAS NO: 30818-28-1
• Molecular Formula: C₇H₄ClNO
• Molecular Weight: 154
• Mol File: 30818-28-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: Benzonitrile, 4-chloro-2-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-chloro-2-hydroxy-(30818-28-1)
• EPA Substance Registry System: Benzonitrile, 4-chloro-2-hydroxy-(30818-28-1)

Safety Data

• Hazardous Substances Data: 30818-28-1(Hazardous Substances Data)

Usage

Uses

4-Chloro-2-hydroxybenzonitrile

Upstream product

• 108-43-0 3-monochlorophenol 
• 203259-52-3 ethyl 6-chloro-1,2-benzisoxazole-3-carboxylate 
• 50620-09-2 6-chloro-benz[d]isoxazole-3-carboxylic acid methyl ester 
• 28691-49-8 6-chlorobenzo[d]isoxazole-3-carboxylic acid 
• 2420-26-0 4-chlorosalicylaldehyde 

Downstream Products

• 133715-45-4 (S)-(+)-1-(5-chloro-2-cyanophenoxy)-2,3-epoxypropane 
• 203259-31-8 (R)-(-)-1-(5-chloro-2-cyanophenoxy)-2,3-epoxypropane 
• 357443-71-1 4-Chloro-2-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-(3-furanyl)butoxy]benzonitrile 
• 357443-74-4 4-Chloro-2-[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-(2-furanyl)butoxy]benzonitrile 

Relevant articles and documents

Nonspecific medium effects versus specific group positioning in the antibody and albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles

The mechanisms by which solvents, antibodies, and albumins influence the rates of base-catalyzed reactions of benzisoxazoles have been explored theoretically. New experimental data on substituent effects and rates of reactions in several solvents, in an antibody, and in an albumin are reported. Quantum mechanical calculations were carried out for the reactions in water and acetonitrile, and docking of the transition state into a homology model of antibody 34E4 and an X-ray structure of human serum albumin was accomplished. A microenvironment made up of catalytic polar groups (glutamate in antibody 34E4 and lysine in human serum albumin) surrounded by relatively nonpolar groups is present in both catalytic proteins.